Cite
HARVARD Citation
Seligmann, J. et al. (2021). Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. Journal of clinical oncology. 39 (33), pp. 3705-3715. [Online].